Skip to main navigation Skip to search Skip to main content

Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)

  • Hongtao Duan
  • , Changjian Shao
  • , Minghong Pan
  • , Honggang Liu
  • , Xiaoping Dong
  • , Yong Zhang
  • , Liping Tong
  • , Yingtong Feng
  • , Yuanyuan Wang
  • , Lu Wang
  • , Neil B. Newman
  • , Inderpal S. Sarkaria
  • , John V. Reynolds
  • , Francesco De Cobelli
  • , Zhiqiang Ma
  • , Tao Jiang
  • , Xiaolong Yan

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science